A Gaseous Debate von Kosters, Michael, MD, Giri, Anshu, MD, Gnanabakthan, Naveen, MD, Katerji, Ibrahim, MD

Volltext

International approaches to head and neck cancer multidisciplinary tumor board von Yao, Christopher MKL, Beatty, Sydney, Giri, Anshu, Liu, Jeffrey Chang-Jen, Bauman, Jessica R, Sturgis, Erich M., Galloway, Thomas James, Ridge, John A.

Volltext

Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer von Burbure, Nina, Handorf, Elizabeth, Ridge, John A., Bauman, Jessica, Liu, Jeffrey C., Giri, Anshu, Galloway, Thomas J.

Volltext

Assessing the acceptability and feasibility of using a computerized food frequency questionnaire (FFQ) to determine dietary patterns in survivors of head and neck cancer (HNC) von Senchak, Jordan, Albert, Madeline, Egleston, Brian L., Galloway, Thomas James, Giri, Anshu, Stromberg, Kara, Costa, Jacquelyn, Liu, Jeffrey, Schmalbach, Cecelia, Vendra, Varun, Fang, Carolyn Y, Jain, Rishi, Bauman, Jessica R

Volltext

Phase I Study of Oral Azacitidine (CC-486) Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma von Hess, Brian T., Cerchietti, Leandro, Hendrickson, Lindsey, Hill, Elizabeth, Giri, Anshu, Salzer, Shanta, Hogan, Sarah, Finch, Lacey, Klingenberg, Robin, Hu, Fang, Wagner-Johnston, Nina D.

Volltext

Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer von Bauman, Julie E, Saba, Nabil F, Roe, Denise, Bauman, Jessica R, Kaczmar, John, Bhatia, Aarti, Muzaffar, Jameel, Julian, Ricklie, Wang, Steven, Bearelly, Shethal, Baker, Audrey, Steuer, Conor, Giri, Anshu, Burtness, Barbara, Centuori, Sara, Caulin, Carlos, Klein, Robert, Saboda, Kathylynn, Obara, Stefanie, Chung, Christine H

Volltext

Prognostic significance of HPV status and treatment modality in hypopharyngeal cancer von Burbure, Nina, Handorf, Elizabeth, Ridge, John A, Bauman, Jessica, Liu, Jeffrey C, Giri, Anshu, Galloway, Thomas J

Volltext

1287: CONSERVATIVE MANAGEMENT OF SPONTANEOUS ESOPHAGEAL PERFORATION IN A PATIENT WITH ACHALASIA von Aleksiejuk, Phillip, Pawar, Leena, Giri, Anshu

Volltext

Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC) von Bauman, Julie E., Saba, Nabil F., Roe, Denise, Bauman, Jessica R., Kaczmar, John M., Bhatia, Aarti K., Muzaffar, Jameel, Julian, Ricklie Ann, Wang, Steven, Bearelly, Shethal, Baker, Audrey, Steuer, Conor Ernst, Giri, Anshu, Burtness, Barbara, Centuori, Sara, Caulin, Carlos, Saboda, Kathylynn, Obara, Stefanie, Chung, Christine H.

Volltext

Outcomes in patients with aggressive B‐cell non‐Hodgkin lymphoma after intensive frontline treatment failure von Ayers, Emily C., Li, Shaoying, Medeiros, L. Jeffrey, Bond, David A., Maddocks, Kami J., Torka, Pallawi, Mier Hicks, Angel, Curry, Madeira, Wagner‐Johnston, Nina D., Karmali, Reem, Behdad, Amir, Fakhri, Bita, Kahl, Brad S., Churnetski, Michael C., Cohen, Jonathon B., Reddy, Nishitha M., Modi, Dipenkumar, Ramchandren, Radhakrishnan, Howlett, Christina, Leslie, Lori A., Cytryn, Samuel, Diefenbach, Catherine S., Faramand, Rawan, Chavez, Julio C., Olszewski, Adam J., Liu, Yang, Barta, Stefan K., Mukhija, Dhruvika, Hill, Brian T., Ma, Helen, Amengual, Jennifer E., Nathan, Sunita, Assouline, Sarit E., Orellana‐Noia, Victor M., Portell, Craig A., Chandar, Ashwin, David, Kevin A., Giri, Anshu, Hess, Brian T., Landsburg, Daniel J.

Volltext

Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge von Kalmuk, James, Puchalla, Jon, Feng, Gong, Giri, Anshu, Kaczmar, John

Volltext

Randomized, phase II study of ficlatuzumab with or without cetuximab in patients with pan-refractory, recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) von Bauman, Julie E., Roe, Denise, Saba, Nabil F., Bauman, Jessica Ruth, Kaczmar, John M., Burtness, Barbara, Muzaffar, Jameel, Julian, Ricklie Ann, Wang, Steven, Bearelly, Shethal, Baker, Audrey, Steuer, Conor Ernst, Bhatia, Aarti K., Giri, Anshu, Caulin, Carlos, Stabile, Laura P., Centuori, Sara, Chung, Christine H.

Volltext

Outcomes of Patients with Limited-Stage Plasmablastic Lymphoma von Hess, Brian T., Giri, Anshu, Park, Yeonhee, Patel, Krina K., Link, Brian K., Nowakowski, Grzegorz S., Maliske, Seth M, Fortin, Sonia, Chavez, Julio C., Saeed, Hayder, Hill, Brian T., Mejia Garcia, Alex V., Maddocks, Kami J., Hanel, Walter, Wagner-Johnston, Nina D., Messmer, Marcus Raymond, Kahl, Brad S., Watkins, Marcus, Alderuccio, Juan Pablo, Lossos, Izidore S., Nathan, Sunita, Orellana-Noia, Victor M., Portell, Craig A., Landsburg, Daniel J., Ayers, Emily C., Castillo, Jorge J.

Volltext

Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study von Hess, Brian T., Giri, Anshu, Park, Yeonhee, Patel, Krina K., Link, Brian K., Nowakowski, Grzegorz S., Maliske, Seth M., Fortin, Sonia, Chavez, Julio C., Saeed, Hayder, Hill, Brian T., Mejia Garcia, Alex V., Maddocks, Kami J., Hanel, Walter, Wagner‐Johnston, Nina D., Messmer, Marcus R., Kahl, Brad S., Watkins, Marcus, Alderuccio, Juan Pablo, Lossos, Izidore S., Nathan, Sunita, Orellana‐Noia, Victor M., Portell, Craig A., Landsburg, Daniel J., Ayers, Emily C., Castillo, Jorge J.

Volltext

Abstract #906: An Unusual Complication of Hormone Therapy in a Transgender Patient von Giri, Anshu, Kosters, Michael, Aleksiejuk, Phillip, Sivalingham, Devamohan, amzuta, ioana

Volltext

53. Clinical utility of molecular profiling in the management of Richter syndrome von Znoyko, Iya, Mazzoni, Sandra, Hess, Brian, Schandl, Cynthia, Haidemenos, Gregory, Chiad, Zane, Kalmuk, James, Giri, Anshu, Wolff, Daynna

Volltext

Outcomes of Patients with Limited-Stage Aggressive Large B-Cell Lymphoma with MYC Rearrangement with and without BCL2 and/or BCL6 Rearrangements: A Retrospective Analysis from 15 U... von Kothari, Shalin K., Li, Shaoying, Medeiros, L. Jeffrey, Ayers, Emily C., Landsburg, Daniel J., Bond, David A., Maddocks, Kami J., Giri, Anshu, Hess, Brian T., Pham, Luu Q., Advani, Ranjana, Liu, Yang, Barta, Stefan Klaus, Vose, Julie M., Churnetski, Michael C., Cohen, Jonathon B., Burkart, Madelyn, Karmali, Reem, Zurko, Joanna, Mehta, Amitkumar, Olszewski, Adam J, Lee, Sarah S, Hill, Brian T., Burns, Timothy F., Lansigan, Frederick, Rabinovich, Emma, Peace, David, Groman, Adrienne, Attwood, Kris, Hernandez-Ilizaliturri, Francisco J., Torka, Pallawi

Volltext

Outcome of Patients with Aggressive B Cell Lymphomas Who Receive Second-Line Salvage Immunochemotherapy Following Treatment Failure of Intensive First-Line Immunochemotherapy von Ayers, Emily C., Li, Shaoying, Medeiros, Jeffrey, Bond, David A., Maddocks, Kami J., Torka, Pallawi, Mier Hicks, Angel, Curry, Madeira, Wagner-Johnston, Nina D., Karmali, Reem, Behdad, Amir, Fakhri, Bita, Kahl, Brad S, Churnetski, Michael C, Cohen, Jonathon B., Reddy, Nishitha, Modi, Dipenkumar, Ramchandren, Radhakrishnan, Howlett, Christina, Leslie, Lori A., Cytryn, Samuel, Diefenbach, Catherine, Faramand, Rawan, Chavez, Julio C., Olszewski, Adam J, Liu, Yang, Barta, Stefan Klaus, Mukhija, Dhruvika, Hill, Brian T., Ma, Helen, Amengual, Jennifer E, Nathan, Sunita, Assouline, Sarit, Orellana-Noia, Victor M., Portell, Craig A., Chandar, Ashwin, David, Kevin A., Giri, Anshu, Hess, Brian T., Landsburg, Daniel J.

Volltext

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics von Torka, Pallawi, Kothari, Shalin K., Sundaram, Suchitra, Li, Shaoying, Medeiros, L. Jeffrey, Ayers, Emily C., Landsburg, Daniel J., Bond, David A., Maddocks, Kami J., Giri, Anshu, Hess, Brian, Pham, Luu Q., Advani, Ranjana, Liu, Yang, Barta, Stefan Klaus, Vose, Julie M., Churnetski, Michael C., Cohen, Jonathon B., Burkart, Madelyn, Karmali, Reem, Zurko, Joanna, Mehta, Amitkumar, Olszewski, Adam J., Lee, Sarah, Hill, Brian T., Burns, Timothy F., Lansigan, Frederick, Rabinovich, Emma, Peace, David, Groman, Adrienne, Attwood, Kristopher, Hernandez-Ilizaliturri, Francisco J.

Volltext

Surface Plasmon Resonance Study of Apoptotic Regulators Bcl-2, Bcl-w, Bcl-XL, and Mcl-1 Indicate That the Preclinical Small Molecule Inhibitor (SMI) TW-37 Binds to the Hydrophobic... von Goustin, Anton-Scott, Giri, Anshu, Wang, Shaomeng, Al-Katib, Ayad, Ramzi, Mohammad M.

Volltext